Skip to content

AIM round-up: Artemis Resources, Bluejay Mining, Crestchic


London’s AIM Index lagged the main board noticeably today, accruing a further five and a half points worth of losses to close the day at 914.28

  • Artemis Resources +37%
  • Bluejay Mining +36%
  • Crestchic +24%
  • Kropz -26%
  • Trellus Health -16%

Artemis Resources [LON:ARV] topped the board again, advancing 37% by the bell. That extends a marked run higher which started after the weekend break, although still only lifts the stock back to levels last seen in May and holding below the IPO price from earlier in the year. Trading volume has certainly been significantly elevated during the session – is news imminent?

Bluejay Mining LON:JAY also saw a solid performance, up 36% at the bell. Again no news but there have been massively elevated levels of trade going through during the session. There are evidently no shortage of sellers either, given the relatively modest spread that’s being quoted.

A notable mention for Crestchic LON:LOAD which impressed the market with a trading update significantly ahead of expectations. The company has benefitted from a series of project extensions, with profits being upgraded for a third time this year as a result. Until June, the company was known as Northbridge Industrial Services, with shares now trading at levels not seen in over seven years.

Kropz LON:KRPZ is the day’s biggest faller, after the company advised of a further production delay this morning. Management also announced that they would be drawing down the last remnants of a convertible loan, would be taking an additional bridging loan whilst also exploring additional financing options to meet working capital needs. Shares finished down 26%.

Trellus Health LON:TRLS also found itself on the radar, but the day was defined by minimal trade and a wide spread. The stock has now lost around 85% of its post-IPO price recorded last May, finishing the day some 16% lower.

Looking for great investing ideas? Sign up to our free newsletter.

This article does not constitute investment advice. Make sure you do your own research or consult a professional advisor.

'How to' Guides

Our latest in-depth company reports

Detailed reviews of selected companies and investment trusts.

On the podcast

Sign up for great investing stock tips

Thanks to our Site Partners

Our partners are established, regulated businesses and we are grateful for their support.

CME Group
FP Markets
Back To Top